Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunityJulia Niessl, Daniel E. Kaufmann, Mila Janković et al.|Nature Medicine|2020Cited by 164
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 studyYehuda Z. Cohen, Marina Caskey, Allison L. Butler et al.|PLoS ONE|2019Cited by 92